E3 ubiquitin ligase E6AP-mediated TSC2 turnover in the presence and absence of HPV16 E6

Genes to Cells

Volumn 13, Issue 3, 2008, Pages 285-294

  Zheng, Li ^a   Ding, Huirong ^a   Lu, Zheming ^a   Li, Yong ^a   Pan, Yaqi ^a   Ning, Tao ^a   Ke, Yang ^a,b  

^a PEKING UNIVERSITY CANCER HOSPITAL AND INSTITUTE   (China)

^b PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

[No Author keywords available]

Indexed keywords

E6 ASSOCIATED PROTEIN; PROTEIN E6; TUMOR SUPPRESSOR PROTEIN; TUMOR SUPPRESSOR PROTEIN 2; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; HALF LIFE TIME; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; TURNOVER TIME; UBIQUITINATION;

BINDING SITES; CELLS, CULTURED; GENE EXPRESSION REGULATION; HELA CELLS; HUMANS; ONCOGENE PROTEINS, VIRAL; REPRESSOR PROTEINS; RNA, SMALL INTERFERING; TUMOR SUPPRESSOR PROTEINS; UBIQUITIN-PROTEIN LIGASES; UBIQUITINATION;

EID: 39749113228     PISSN: 13569597     EISSN: 13652443     Source Type: Journal    
DOI: 10.1111/j.1365-2443.2008.01162.x     Document Type: Article

References (44)

1. Bosch, F.X., Lorincz, A., Munoz, N., Meijer, C.J. & Shah, K.V. (2002) The causal relation between HPV and cervical cancer. J. Clin. Pathol. 55, 244-265.
2. Chong-Kopera, H., Inoki, K., Li, Y., Zhu, T., Garcia-Gonzalo, F.R., Rosa, J.L. & Guan, K.L. (2006) TSC1 stabilizes TSC2 by inhibiting the interaction between TSC2 and the HERC1 ubiquitin ligase. J. Biol. Chem. 281, 8313-8316.
3. Dyson, N., Howley, P.M., Munger, K. & Harlow, E. (1989) The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science 243, 934-937.
4. Gao, Q., Kumar, A., Singh, L., Huibregtse, J.M., Beaudenon, S., Srinivasan, S., Wazer, D.E., Band, H. & Band, V. (2002a) Human Papillomavirus E6-induced degradation of E6TP1 is mediated by E6AP ubiquitin ligase1. Cancer Res. 62, 3315-3321.
5. Gao, X., Zhang, Y., Arrazola, P., Hino, O., Kobayashi, T., Yeung, R.S., Ru, B. & Pan, D. (2002b) TSC tumour suppressor proteins antagonize amino-acid-TOR signalling. Nat. Cell Biol. 4, 699-704.
6. Garami, A., Zwartkruis, F.J.T., Nobukuni, T., Joaquin, M., Roccio, M., Stocker, H., Kozma, S., Hafen, E., Bos, J.L. & Thomas, G. (2003) Insulin activation of Rheb, a mediator of mTOR/S6K/4E-BP signaling, is inhibited by TSC1 and 2. Mol. Cell 11, 1457-1466.
7. Harris, K.F., Shoji, I., Cooper, E.M., Kumar, S., Oda, H., & Howley, P.M. (1999) Ubiquitin-mediated degradation of active Src tyrosine kinase. Proc. Natl. Acad. Sci. USA 96, 13738-13743.
8. Hawley-Nelson, P., Vousden, K.H., Hubbert, N.L., Lowy, D.R. & Schiller, J.T. (1989) HPV16 E6 and E7 proteins cooperate to immortalize human foreskin keratinocytes. EMBO J. 8, 3905-3910.
9. Hay, N. & Sonenberg, N. (2004) Upstream and downstream of mTOR. Genes Dev. 18, 1926-1945.
10. Heck, D.V., Yee, C.L., Howley, P.M. & Munger, K. (1992) Efficiency of binding the retinoblastoma protein correlates with the transforming capacity of the E7 oncoproteins of the human papillomaviruses. Proc. Natl. Acad. Sci. USA 89, 4442-4446.
11. Hudson, J.B., Bedell, M.A., McCance, D.J. & Laiminis, L.A. (1990) Immortalization and altered differentiation of human keratinocytes in vitro by the E6 and E7 open reading frames of human papillomavirus type 18. J. Virol. 64, 519-526.
12. Huibregtse, J.M., Scheffner, M., Beaudenon, S. & Howley, P. (1995) A family of proteins structurally and functionally related to the E6-AP ubiquitin-protein ligase. Proc. Natl. Acad. Sci. USA 92, 2563-2567.
13. Huibregtse, J.M., Scheffner, M. & Howley, P.M. (1991) A cellular protein mediates association of p53 with the E6 oncoprotein of human papillomavirus types 16 or 18. EMBO J. 10, 4129-4135.
14. Huibregtse, J.M., Scheffner, M. & Howley, P.M. (1993a) Cloning and expression of the cDNA for E6-AP, a protein that mediates the interaction of the human papillomavirus E6 oncoprotein with p53. Mol. Cell. Biol. 13, 775-784.
15. Huibregtse, J.M., Scheffner, M. & Howley, P.M. (1993b) Localization of the E6-AP regions that direct human papillomavirus E6 binding, association with p53 ubiquitination of associated proteins. Mol. Cell. Biol. 13, 4918-4927.
16. Inoki, K. & Guan, K. (2006) Complexity of the TOR signaling network. Trends Cell Biol. 16, 206-212.
17. Inoki, K., Li, Y., Xu, T. & Guan, K.L. (2003) Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling. Genes Dev. 17, 1829-1834.
18. Kelley, M.L., Keiger, K.E., Lee, C.J. & Huibregtse, J.M. (2005) The global transcriptional effects of the human papillomavirus E6 protein in cervical carcinoma cell lines are mediated by the E6AP ubiquitin ligase. J. Virol. 79, 3737-3747.
19. Kuhne, C. & Banks, L. (1998) E3-ubiquitin ligase/E6-AP links multicopy maintenance protein 7 to the ubiquitination pathway by a novel motif, the L2G box. J. Biol. Chem. 273, 34302-34309.
20. Kumar, S., Talis, A.L. & Howley, P.M. (1999) Identification of HHR23A as a substrate for E6-associated protein-mediated ubiquitination. J. Biol. Chem. 274, 18785-18792.
21. Kwiatkowski, D.J. (2003) Tuberous sclerosis: From tubers to mTOR. Ann. Hum. Genet. 67, 87-96.
22. Lu, Z., Hu, X., Li, Y., Zheng, L., Zhou, Y., Jiang, H., Ning, T., Basang, Z., Zhang, C. & Ke, Y. (2004) Human papillomavirus 16 E6 oncoprotein interferences with insulin signaling pathway by binding to tuberin. J. Biol. Chem. 279, 35664-35670.
23. Ma, L., Chen, Z., Erdjument-Bromage, H., Tempst, P. & Pandolfi, P.P. (2005) Phosphorylation and functional inactivation of TSC2 by Erk implications for tuberous sclerosis and cancer pathogenesis. Cell 121, 179-193.
24. Manning, B.D. & Cantley, L.C. (2003) Rheb fills a GAP between TSC and TOR. Trends Biochem. Sci. 28, 573-576.
25. Mantovani, F. & Banks, L. (2001) The human papillomavirus E6 protein and its contribution to malignant progression. Oncogene 20, 7874-7887.
26. Miloloza, A., Rosner, M., Nellist, M., Halley, D., Bernaschek, G. & Hengstschläger, M. (2000) The TSC1 gene product, hamartin, negatively regulates cell proliferation. Hum. Mol. Genet. 9, 1721-1727.
27. Munger, K., Werness, B.A., Dyson, N., Phelps, W.C., Harlow, E. & Howley, P.M. (1989) Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor gene product. EMBO J. 8, 4099-4105.
28. Nakagawa, S. & Huibregtse, J.M. (2000) Human scribble (Vartul) is targeted for ubiquitin-mediated degradation by the high-risk papillomavirus E6 proteins and the E6AP ubiquitin-protein ligase. Mol. Cell. Biol. 20, 8244-8253.
29. Oda, H., Kumar, S. & Howley, P. (1999) Regulation of the Src family tyrosine kinase Blk through E6AP-mediated ubiquitination. Proc. Natl. Acad. Sci. USA 96, 9557-9562.
30. Rosner, M., Freilinger, A. & Hengstschläger, M. (2004) Proteins interacting with the tuberous sclerosis gene products. Amino Acids 27, 119-128.
31. Rosner, M., Hofer, K., Kubista, M. & Hengstschläger, M. (2003) Cell size regulation by the human TSC tumor suppressor proteins depends on PI3K and FKBP38. Oncogene 22, 4786-4798.
32. Roux, P.P., Balliff, B.A., Anjum, R., Gygi, S.P. & Blenis, J. (2004) Tumor-promoting phorbol esters and activated Ras inactivate the tuberous sclerosis tumor suppressor complex via p90 ribosomal S6 kinase. Proc. Natl. Acad. Sci. USA 101, 13489-13494.
33. Saucedo, L.J., Gao, X., Chiarelli, D.A., Li, L., Pan, D. & Edgar, B.A. (2003) Rheb promotes cell growth as a component of the insulin/TOR signalling network. Nat. Cell Biol. 5, 566-571.
34. Scheffner, M., Werness, B.A., Huibregtse, J.M., Levine, A.J. & Howley, P.M. (1990) The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63, 1129-1136.
35. Scheffner, M. & Whitaker, N.J. (2003) Human papillomavirusinduced carcinogenesis and the ubiquitin-proteasome system. Semin. Cancer Biol. 13, 59-67.
36. 3K and mTOR signalling controls tumour cell growth. Nature 441, 424-430.
37. Soucek, T., Hölzl, G., Bernaschek, G. & Hengstschläger, M. (1998a) A role of the tuberous sclerosis gene-2 product during neuronal differentiation. Oncogene 16, 2197-2204.
38. Soucek, T., Pusch, O., Wienecke, R., DeClue, J.E. & Hengstschläger, M. (1997) Role of the tuberous sclerosis gene-2 product in cell cycle control. Loss of the tuberous sclerosis gene-2 induces quiescent cells to enter S phase. J. Biol. Chem. 272, 29301-29308.
39. Soucek, T., Yeung, R.S. & Hengstschläger, M. (1998b) Inactivation of the cyclin-dependent kinase inhibitor p27 upon loss of the tuberous sclerosis complex gene-2. Proc. Natl. Acad. Sci. USA 95, 15653-15658.
40. Stocker, H., Radimerski, T., Schindelholz, B., Wittwer, F., Belawat, P., Daram, P., Breuer, S., Thomas, G. & Hafen, E. (2003) Rheb is an essential regulator of S6K in controlling cell growth in Drosophila. Nat. Cell Biol. 5, 559-565.
41. Talis, A.L., Huibregtse, J.M. & Howley, P.M. (1998) The role of E6AP in the regulation of p53 protein levels in human papillomavirus (HPV)-positive and HPV-negative cells. J. Biol. Chem. 273, 6439-6445.
42. Thomas, M. & Banks, L. (1998) Inhibition of Bak-induced apoptosis by HPV-18 E6. Oncogene 17, 2943-2954.
43. Werness, B.A., Levine, A.J. & Howley, P.M. (1990) Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science 248, 76-79.
44. zur Hausen, H. (2002) Papillomaviruses and cancer: From basic studies to clinical application. Nat. Rev. Cancer 2, 342-350.